

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.55214178 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.17550708 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 7.17550708 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.96749665 |
| 5 | respiratory electron transport chain (GO:0022904) | 6.10018923 |
| 6 | electron transport chain (GO:0022900) | 5.98468985 |
| 7 | protein neddylation (GO:0045116) | 5.44855590 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 5.42916183 |
| 9 | protein complex biogenesis (GO:0070271) | 4.74323139 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 4.38587915 |
| 11 | GTP biosynthetic process (GO:0006183) | 4.37127348 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.23597720 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.23597720 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.23597720 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.19655712 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.16101146 |
| 17 | * hydrogen ion transmembrane transport (GO:1902600) | 4.11154544 |
| 18 | viral transcription (GO:0019083) | 4.04959054 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 3.96683429 |
| 20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.87928435 |
| 21 | protein targeting to ER (GO:0045047) | 3.87461850 |
| 22 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.79788187 |
| 23 | translational termination (GO:0006415) | 3.78310616 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 3.75176356 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.72438653 |
| 26 | * proton transport (GO:0015992) | 3.71163593 |
| 27 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.70470995 |
| 28 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.68729490 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 3.67722085 |
| 30 | regulation of oxidative phosphorylation (GO:0002082) | 3.67056195 |
| 31 | * ATP hydrolysis coupled proton transport (GO:0015991) | 3.66266840 |
| 32 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.66266840 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.63911444 |
| 34 | ATP biosynthetic process (GO:0006754) | 3.63405570 |
| 35 | regulation of mitochondrial translation (GO:0070129) | 3.63367587 |
| 36 | * hydrogen transport (GO:0006818) | 3.62846309 |
| 37 | platelet dense granule organization (GO:0060155) | 3.57345140 |
| 38 | UTP biosynthetic process (GO:0006228) | 3.55433493 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 3.50627406 |
| 40 | dopamine transport (GO:0015872) | 3.47715073 |
| 41 | proteasome assembly (GO:0043248) | 3.39494982 |
| 42 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.33767450 |
| 43 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.30777300 |
| 44 | * phagosome maturation (GO:0090382) | 3.28953870 |
| 45 | inner mitochondrial membrane organization (GO:0007007) | 3.28886215 |
| 46 | signal peptide processing (GO:0006465) | 3.28266074 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.20064619 |
| 48 | viral life cycle (GO:0019058) | 3.18677535 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18034555 |
| 50 | purine nucleotide salvage (GO:0032261) | 3.14442684 |
| 51 | cellular protein complex disassembly (GO:0043624) | 3.14039914 |
| 52 | protein targeting to mitochondrion (GO:0006626) | 3.11069021 |
| 53 | * transferrin transport (GO:0033572) | 3.09444449 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.08593087 |
| 55 | amino sugar catabolic process (GO:0046348) | 3.07740524 |
| 56 | translational elongation (GO:0006414) | 3.07446655 |
| 57 | CTP metabolic process (GO:0046036) | 3.05798222 |
| 58 | CTP biosynthetic process (GO:0006241) | 3.05798222 |
| 59 | establishment of protein localization to mitochondrion (GO:0072655) | 3.03982733 |
| 60 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.02377341 |
| 61 | dopamine biosynthetic process (GO:0042416) | 2.99663610 |
| 62 | UTP metabolic process (GO:0046051) | 2.99181150 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.98623477 |
| 64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.96670353 |
| 65 | protein-cofactor linkage (GO:0018065) | 2.96014799 |
| 66 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94893941 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94893941 |
| 68 | glycosphingolipid catabolic process (GO:0046479) | 2.93379266 |
| 69 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.92491593 |
| 70 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.91992993 |
| 71 | positive regulation of TOR signaling (GO:0032008) | 2.90733443 |
| 72 | positive regulation of prostaglandin secretion (GO:0032308) | 2.87879880 |
| 73 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.87857391 |
| 74 | sequestering of actin monomers (GO:0042989) | 2.86380177 |
| 75 | translation (GO:0006412) | 2.85977779 |
| 76 | oxidative phosphorylation (GO:0006119) | 2.85746126 |
| 77 | metallo-sulfur cluster assembly (GO:0031163) | 2.85185096 |
| 78 | iron-sulfur cluster assembly (GO:0016226) | 2.85185096 |
| 79 | purine-containing compound salvage (GO:0043101) | 2.84098186 |
| 80 | protein deneddylation (GO:0000338) | 2.82900836 |
| 81 | protein localization to mitochondrion (GO:0070585) | 2.82565068 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.81952575 |
| 83 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.80711684 |
| 84 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.80711684 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.80655434 |
| 86 | * trivalent inorganic cation transport (GO:0072512) | 2.77699166 |
| 87 | * ferric iron transport (GO:0015682) | 2.77699166 |
| 88 | oligosaccharide catabolic process (GO:0009313) | 2.77479107 |
| 89 | termination of RNA polymerase III transcription (GO:0006386) | 2.76809855 |
| 90 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76809855 |
| 91 | protein localization to cilium (GO:0061512) | 2.76758894 |
| 92 | positive regulation of ligase activity (GO:0051351) | 2.76347236 |
| 93 | regulation of dopamine metabolic process (GO:0042053) | 2.74598781 |
| 94 | regulation of catecholamine metabolic process (GO:0042069) | 2.74598781 |
| 95 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.73966424 |
| 96 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.73789794 |
| 97 | intracellular protein transmembrane import (GO:0044743) | 2.73381975 |
| 98 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.70256966 |
| 99 | viral protein processing (GO:0019082) | 2.69920155 |
| 100 | cellular response to zinc ion (GO:0071294) | 2.68216022 |
| 101 | protein targeting to membrane (GO:0006612) | 2.67303550 |
| 102 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.65392913 |
| 103 | eosinophil chemotaxis (GO:0048245) | 2.62554379 |
| 104 | cullin deneddylation (GO:0010388) | 2.62304391 |
| 105 | glycolipid catabolic process (GO:0019377) | 2.62085467 |
| 106 | mannosylation (GO:0097502) | 2.60854303 |
| 107 | rRNA modification (GO:0000154) | 2.60660253 |
| 108 | aldehyde catabolic process (GO:0046185) | 2.60230367 |
| 109 | protein maturation by protein folding (GO:0022417) | 2.57782877 |
| 110 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.56499146 |
| 111 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.56499146 |
| 112 | positive regulation of mitochondrial fission (GO:0090141) | 2.55545472 |
| 113 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.54644670 |
| 114 | regulation of cellular amine metabolic process (GO:0033238) | 2.53938849 |
| 115 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.52463431 |
| 116 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.52205750 |
| 117 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.52205750 |
| 118 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.52205750 |
| 119 | aerobic respiration (GO:0009060) | 2.49322289 |
| 120 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49141011 |
| 121 | negative regulation of ligase activity (GO:0051352) | 2.49141011 |
| 122 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.48744524 |
| 123 | establishment of viral latency (GO:0019043) | 2.48739141 |
| 124 | mitochondrial transport (GO:0006839) | 2.47138359 |
| 125 | translational initiation (GO:0006413) | 2.46898501 |
| 126 | regulation of cellular respiration (GO:0043457) | 2.45780576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.56602160 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.91000549 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.60305403 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.53513677 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.42055095 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25749267 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.15169183 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.03807341 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97673657 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.92115397 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.84300271 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.56789014 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.36006774 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35572038 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33117561 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30150157 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24438832 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.22205976 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15028480 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12223200 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08035127 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.99136004 |
| 23 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.92140876 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88326325 |
| 25 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79474573 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78439707 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72711930 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.71970263 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71841890 |
| 30 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.66386653 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65236974 |
| 32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62814934 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.60819982 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60671849 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58592601 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57807067 |
| 37 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57072972 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55377120 |
| 39 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.51053991 |
| 40 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.51009988 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49638571 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45355765 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45070645 |
| 44 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42187047 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41203169 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39756882 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38559614 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.37843195 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36657123 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35737259 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.35484309 |
| 52 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.35312859 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34900885 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33031504 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.32961110 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31394710 |
| 57 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.31248136 |
| 58 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.28494366 |
| 59 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28404083 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28211837 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28124178 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26174374 |
| 63 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21429685 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20914727 |
| 65 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20856791 |
| 66 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20166916 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19781927 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.15572280 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14663630 |
| 70 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.12459060 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11563626 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11127130 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11000293 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10955057 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10925504 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10515468 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10168092 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09369878 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09161194 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09109202 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08974435 |
| 82 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08879161 |
| 83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08297348 |
| 84 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07548848 |
| 85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06634740 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06083311 |
| 87 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05820030 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05333462 |
| 89 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05062519 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04702995 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04210620 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03844863 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03843882 |
| 94 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02021757 |
| 95 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00023247 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99472777 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99186977 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99000591 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98349670 |
| 100 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.98028477 |
| 101 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97491449 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94268597 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94222341 |
| 104 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94144984 |
| 105 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93373146 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93145720 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92227281 |
| 108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92096949 |
| 109 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91885488 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91827365 |
| 111 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91817532 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91443486 |
| 113 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91352157 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91202222 |
| 115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90203717 |
| 116 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90153302 |
| 117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90023427 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89989935 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89682092 |
| 120 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89497375 |
| 121 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89370020 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88373075 |
| 123 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87272540 |
| 124 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87096542 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86987481 |
| 126 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86462078 |
| 127 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86220988 |
| 128 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86154389 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85612373 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85360095 |
| 131 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84835224 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84053969 |
| 133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83711397 |
| 134 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.82654054 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82616621 |
| 136 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82040307 |
| 137 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81689601 |
| 138 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81601135 |
| 139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81289081 |
| 140 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80373307 |
| 141 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.79764874 |
| 142 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79377236 |
| 143 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.76801178 |
| 144 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.75670877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.27158677 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.74520762 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.45078411 |
| 4 | MP0001529_abnormal_vocalization | 3.17748425 |
| 5 | MP0009840_abnormal_foam_cell | 2.99521140 |
| 6 | MP0001905_abnormal_dopamine_level | 2.99005299 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.70874335 |
| 8 | MP0002736_abnormal_nociception_after | 2.67378415 |
| 9 | MP0000343_altered_response_to | 2.65771241 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.54075909 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.48167271 |
| 12 | MP0004270_analgesia | 2.44209514 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.41293791 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.39078084 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.34285968 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.15229728 |
| 17 | MP0002064_seizures | 2.11709505 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.08449696 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.03558103 |
| 20 | MP0002272_abnormal_nervous_system | 2.01024693 |
| 21 | MP0001970_abnormal_pain_threshold | 2.00058097 |
| 22 | MP0009745_abnormal_behavioral_response | 1.99992604 |
| 23 | MP0003075_altered_response_to | 1.96933196 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.92598743 |
| 25 | MP0004142_abnormal_muscle_tone | 1.92116415 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.91143882 |
| 27 | MP0009046_muscle_twitch | 1.87899911 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.87896565 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.84361692 |
| 30 | MP0002163_abnormal_gland_morphology | 1.83749573 |
| 31 | MP0009785_altered_susceptibility_to | 1.83321215 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.81451645 |
| 33 | MP0003724_increased_susceptibility_to | 1.80665375 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.79921134 |
| 35 | MP0000604_amyloidosis | 1.79421912 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.74456573 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.73686556 |
| 38 | MP0003635_abnormal_synaptic_transmissio | 1.73004652 |
| 39 | MP0001853_heart_inflammation | 1.69877466 |
| 40 | MP0003136_yellow_coat_color | 1.65777047 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.64647086 |
| 42 | MP0009764_decreased_sensitivity_to | 1.61211543 |
| 43 | MP0005171_absent_coat_pigmentation | 1.49546955 |
| 44 | MP0001764_abnormal_homeostasis | 1.48313978 |
| 45 | MP0003303_peritoneal_inflammation | 1.48289537 |
| 46 | MP0003011_delayed_dark_adaptation | 1.46110082 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.46031250 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.45396849 |
| 49 | MP0004859_abnormal_synaptic_plasticity | 1.42659592 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.41074629 |
| 51 | MP0001188_hyperpigmentation | 1.39728081 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.39469775 |
| 53 | MP0005671_abnormal_response_to | 1.36938594 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.36901274 |
| 55 | MP0004510_myositis | 1.36861872 |
| 56 | MP0003186_abnormal_redox_activity | 1.36128458 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.35844958 |
| 58 | MP0006082_CNS_inflammation | 1.35155412 |
| 59 | MP0000920_abnormal_myelination | 1.34751506 |
| 60 | MP0001984_abnormal_olfaction | 1.34684443 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.26179635 |
| 62 | MP0000358_abnormal_cell_content/ | 1.25095311 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.24378721 |
| 64 | MP0005025_abnormal_response_to | 1.23429773 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.22020559 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21129640 |
| 67 | MP0008260_abnormal_autophagy | 1.19504897 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.19471037 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.18666634 |
| 70 | MP0004742_abnormal_vestibular_system | 1.17157704 |
| 71 | MP0005409_darkened_coat_color | 1.16428597 |
| 72 | MP0003436_decreased_susceptibility_to | 1.16279838 |
| 73 | MP0005408_hypopigmentation | 1.15850837 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.14735039 |
| 75 | MP0004924_abnormal_behavior | 1.13079290 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.13079290 |
| 77 | MP0001486_abnormal_startle_reflex | 1.11974442 |
| 78 | MP0004043_abnormal_pH_regulation | 1.11363398 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 1.09326846 |
| 80 | MP0005387_immune_system_phenotype | 1.07684733 |
| 81 | MP0001790_abnormal_immune_system | 1.07684733 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.07240731 |
| 83 | MP0008995_early_reproductive_senescence | 1.05945003 |
| 84 | MP0002419_abnormal_innate_immunity | 1.04813746 |
| 85 | MP0002184_abnormal_innervation | 1.04653959 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.04494213 |
| 87 | MP0006292_abnormal_olfactory_placode | 1.03062851 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.03053334 |
| 89 | MP0008469_abnormal_protein_level | 1.01770431 |
| 90 | MP0003195_calcinosis | 1.01543188 |
| 91 | MP0005535_abnormal_body_temperature | 1.00979306 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 1.00911137 |
| 93 | MP0005646_abnormal_pituitary_gland | 1.00118522 |
| 94 | MP0008872_abnormal_physiological_respon | 0.99813151 |
| 95 | MP0003122_maternal_imprinting | 0.99304415 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.98552340 |
| 97 | MP0002723_abnormal_immune_serum | 0.97810362 |
| 98 | MP0002822_catalepsy | 0.96588490 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.96239873 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.96145362 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.95718738 |
| 102 | MP0003633_abnormal_nervous_system | 0.94977164 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.94827042 |
| 104 | MP0003879_abnormal_hair_cell | 0.94532791 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.94223335 |
| 106 | MP0005166_decreased_susceptibility_to | 0.93436893 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.91315826 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.90251205 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.90204420 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.90204420 |
| 111 | MP0005253_abnormal_eye_physiology | 0.89838031 |
| 112 | MP0002751_abnormal_autonomic_nervous | 0.89505166 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.88962149 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.88430038 |
| 115 | MP0004147_increased_porphyrin_level | 0.88004694 |
| 116 | MP0002229_neurodegeneration | 0.87796608 |
| 117 | MP0001664_abnormal_digestion | 0.87069158 |
| 118 | MP0005075_abnormal_melanosome_morpholog | 0.87059007 |
| 119 | MP0005310_abnormal_salivary_gland | 0.86380192 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.86244581 |
| 121 | MP0005499_abnormal_olfactory_system | 0.85927847 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.85927847 |
| 123 | MP0002132_abnormal_respiratory_system | 0.84502140 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.82559510 |
| 125 | MP0003786_premature_aging | 0.82219091 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.81753298 |
| 127 | MP0008058_abnormal_DNA_repair | 0.81659456 |
| 128 | MP0000681_abnormal_thyroid_gland | 0.81571678 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.81519650 |
| 130 | MP0001819_abnormal_immune_cell | 0.81263177 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80638265 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.79884612 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.79450887 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.79339895 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.79130433 |
| 136 | MP0002090_abnormal_vision | 0.78717658 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.78599873 |
| 138 | MP0005551_abnormal_eye_electrophysiolog | 0.77798625 |
| 139 | MP0005410_abnormal_fertilization | 0.76119573 |
| 140 | MP0003329_amyloid_beta_deposits | 0.73595172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.65037248 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.98514773 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.86546139 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.55367108 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.31040059 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.31040059 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.31040059 |
| 8 | Acute encephalopathy (HP:0006846) | 5.19245270 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.88864271 |
| 10 | Increased CSF lactate (HP:0002490) | 4.81903046 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 4.63911907 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 4.36157536 |
| 13 | Hepatic necrosis (HP:0002605) | 4.02229857 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.99862079 |
| 15 | Hypothermia (HP:0002045) | 3.90075869 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.74261268 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.73201252 |
| 18 | Mutism (HP:0002300) | 3.61575967 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.54876279 |
| 20 | Optic disc pallor (HP:0000543) | 3.46961905 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 3.42135083 |
| 22 | Leukodystrophy (HP:0002415) | 3.40841527 |
| 23 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.36139292 |
| 24 | Exertional dyspnea (HP:0002875) | 3.35691828 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.34869742 |
| 26 | Respiratory failure (HP:0002878) | 3.33116427 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.30379684 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.30379684 |
| 29 | Exercise intolerance (HP:0003546) | 3.28468669 |
| 30 | Cerebral edema (HP:0002181) | 3.24563856 |
| 31 | Myokymia (HP:0002411) | 3.15640369 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 3.10002788 |
| 33 | Lactic acidosis (HP:0003128) | 3.05601571 |
| 34 | Abnormality of renal resorption (HP:0011038) | 3.00603039 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.99987701 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.94165441 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.94138465 |
| 38 | Increased serum lactate (HP:0002151) | 2.83805007 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.81259793 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.81114390 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.81114390 |
| 42 | Loss of speech (HP:0002371) | 2.79209000 |
| 43 | Parakeratosis (HP:0001036) | 2.78641764 |
| 44 | Pheochromocytoma (HP:0002666) | 2.77842705 |
| 45 | Increased muscle lipid content (HP:0009058) | 2.75810208 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.74222445 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.61933381 |
| 48 | Cholecystitis (HP:0001082) | 2.61933381 |
| 49 | Abnormality of the anterior horn cell (HP:0006802) | 2.61797312 |
| 50 | Degeneration of anterior horn cells (HP:0002398) | 2.61797312 |
| 51 | Limb dystonia (HP:0002451) | 2.61293846 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.60980190 |
| 53 | Respiratory difficulties (HP:0002880) | 2.56151185 |
| 54 | Reticulocytopenia (HP:0001896) | 2.44816326 |
| 55 | Disinhibition (HP:0000734) | 2.37585237 |
| 56 | Nausea (HP:0002018) | 2.37106583 |
| 57 | Abnormal hair whorl (HP:0010721) | 2.34000279 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.33331136 |
| 59 | Petechiae (HP:0000967) | 2.32617287 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.28463228 |
| 61 | X-linked dominant inheritance (HP:0001423) | 2.26351976 |
| 62 | Prolonged neonatal jaundice (HP:0006579) | 2.25101916 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.24880947 |
| 64 | Aplastic anemia (HP:0001915) | 2.24145275 |
| 65 | Macrocytic anemia (HP:0001972) | 2.23944509 |
| 66 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23168432 |
| 67 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.19927597 |
| 68 | Focal motor seizures (HP:0011153) | 2.18668921 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.18485927 |
| 70 | Recurrent abscess formation (HP:0002722) | 2.17428725 |
| 71 | Abnormal pupillary function (HP:0007686) | 2.15166196 |
| 72 | Axonal loss (HP:0003447) | 2.13076788 |
| 73 | Emotional lability (HP:0000712) | 2.10766712 |
| 74 | Pallor (HP:0000980) | 2.10368811 |
| 75 | Poor head control (HP:0002421) | 2.09883270 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.09688212 |
| 77 | Lethargy (HP:0001254) | 2.07476735 |
| 78 | Nuclear cataract (HP:0100018) | 2.06600758 |
| 79 | Increased IgM level (HP:0003496) | 2.05490956 |
| 80 | Renal tubular dysfunction (HP:0000124) | 2.00708902 |
| 81 | Gait imbalance (HP:0002141) | 2.00476627 |
| 82 | Abnormality of urine glucose concentration (HP:0011016) | 2.00120270 |
| 83 | Glycosuria (HP:0003076) | 2.00120270 |
| 84 | Congenital primary aphakia (HP:0007707) | 1.97590273 |
| 85 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95628770 |
| 86 | Poor suck (HP:0002033) | 1.95541121 |
| 87 | Cerebral hemorrhage (HP:0001342) | 1.95420021 |
| 88 | Recurrent bacterial skin infections (HP:0005406) | 1.95237645 |
| 89 | Abnormal ciliary motility (HP:0012262) | 1.93186224 |
| 90 | Abnormality of macrophages (HP:0004311) | 1.92537376 |
| 91 | CNS demyelination (HP:0007305) | 1.91555351 |
| 92 | Visual hallucinations (HP:0002367) | 1.89863642 |
| 93 | Progressive microcephaly (HP:0000253) | 1.88519173 |
| 94 | Agnosia (HP:0010524) | 1.88460800 |
| 95 | Abnormal urine phosphate concentration (HP:0012599) | 1.88205992 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.87317878 |
| 97 | Multiple enchondromatosis (HP:0005701) | 1.87066125 |
| 98 | Hepatosplenomegaly (HP:0001433) | 1.86652055 |
| 99 | Methylmalonic aciduria (HP:0012120) | 1.86447446 |
| 100 | Atonic seizures (HP:0010819) | 1.86265539 |
| 101 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.85990436 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84598502 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 1.84598502 |
| 104 | Delusions (HP:0000746) | 1.84582761 |
| 105 | Retinal dysplasia (HP:0007973) | 1.84535458 |
| 106 | Vaginal atresia (HP:0000148) | 1.84301750 |
| 107 | Type I transferrin isoform profile (HP:0003642) | 1.84221927 |
| 108 | Diminished motivation (HP:0000745) | 1.83381559 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81170792 |
| 110 | Genital tract atresia (HP:0001827) | 1.79856254 |
| 111 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79775445 |
| 112 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79775445 |
| 113 | Myoclonus (HP:0001336) | 1.78636325 |
| 114 | Apathy (HP:0000741) | 1.77031595 |
| 115 | Retinal atrophy (HP:0001105) | 1.74767869 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70074967 |
| 117 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.69876229 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69336640 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69336640 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69336640 |
| 121 | CNS hypomyelination (HP:0003429) | 1.69152774 |
| 122 | Focal dystonia (HP:0004373) | 1.67743661 |
| 123 | Opisthotonus (HP:0002179) | 1.67613193 |
| 124 | Sensory axonal neuropathy (HP:0003390) | 1.67609765 |
| 125 | Vomiting (HP:0002013) | 1.67398779 |
| 126 | Polyphagia (HP:0002591) | 1.65621550 |
| 127 | Abnormality of magnesium homeostasis (HP:0004921) | 1.65542460 |
| 128 | Hypomagnesemia (HP:0002917) | 1.64261484 |
| 129 | Anxiety (HP:0000739) | 1.63289090 |
| 130 | Peripheral hypomyelination (HP:0007182) | 1.62482880 |
| 131 | Absent/shortened dynein arms (HP:0200106) | 1.61247362 |
| 132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.61247362 |
| 133 | Absence seizures (HP:0002121) | 1.61138670 |
| 134 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.59560327 |
| 135 | Stomatitis (HP:0010280) | 1.54350657 |
| 136 | Progressive inability to walk (HP:0002505) | 1.53820512 |
| 137 | Blindness (HP:0000618) | 1.52165977 |
| 138 | Hypokinesia (HP:0002375) | 1.50890392 |
| 139 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.50066251 |
| 140 | Dialeptic seizures (HP:0011146) | 1.50061392 |
| 141 | Obstructive lung disease (HP:0006536) | 1.49666202 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.49666202 |
| 143 | Gliosis (HP:0002171) | 1.46990691 |
| 144 | Dysautonomia (HP:0002459) | 1.46519291 |
| 145 | Psychosis (HP:0000709) | 1.46480225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.55336951 |
| 2 | VRK2 | 4.42006114 |
| 3 | STK16 | 3.41700534 |
| 4 | CDK19 | 2.90319562 |
| 5 | ARAF | 2.83799877 |
| 6 | MST4 | 2.69366702 |
| 7 | NME2 | 2.67663459 |
| 8 | BCKDK | 2.62735338 |
| 9 | NME1 | 2.58225642 |
| 10 | RIPK4 | 2.47807989 |
| 11 | GRK5 | 2.37283030 |
| 12 | CASK | 2.36465805 |
| 13 | PBK | 2.26221852 |
| 14 | BMPR1B | 2.13956601 |
| 15 | PDK2 | 1.87415195 |
| 16 | PIM2 | 1.85867564 |
| 17 | GRK7 | 1.80087781 |
| 18 | ADRBK2 | 1.74034393 |
| 19 | OXSR1 | 1.70887811 |
| 20 | TAOK2 | 1.67351820 |
| 21 | MAPKAPK5 | 1.65548574 |
| 22 | MYLK | 1.65032915 |
| 23 | BMPR2 | 1.62725795 |
| 24 | MAP2K7 | 1.58845371 |
| 25 | MUSK | 1.57012314 |
| 26 | MAP4K2 | 1.56076433 |
| 27 | STK39 | 1.50956074 |
| 28 | VRK1 | 1.35647208 |
| 29 | BCR | 1.33188344 |
| 30 | WNK4 | 1.25742393 |
| 31 | TNIK | 1.25429270 |
| 32 | CSNK1A1L | 1.25084853 |
| 33 | SIK3 | 1.23172631 |
| 34 | TESK2 | 1.20797491 |
| 35 | NTRK3 | 1.18736453 |
| 36 | TRIM28 | 1.18287016 |
| 37 | EIF2AK1 | 1.17401795 |
| 38 | LIMK1 | 1.16821039 |
| 39 | CCNB1 | 1.14513346 |
| 40 | CAMK2B | 1.07595380 |
| 41 | PLK2 | 1.06084204 |
| 42 | TLK1 | 1.04567086 |
| 43 | CSNK1G1 | 1.04417387 |
| 44 | NEK1 | 1.03457094 |
| 45 | BLK | 1.02306776 |
| 46 | SYK | 0.98668935 |
| 47 | MATK | 0.98368994 |
| 48 | BRAF | 0.97871302 |
| 49 | BUB1 | 0.96139923 |
| 50 | DAPK1 | 0.94815581 |
| 51 | IRAK4 | 0.94493674 |
| 52 | ABL2 | 0.92624078 |
| 53 | TXK | 0.91790715 |
| 54 | PNCK | 0.91642903 |
| 55 | MAPK15 | 0.88653903 |
| 56 | TESK1 | 0.87613355 |
| 57 | DAPK3 | 0.83653564 |
| 58 | DYRK2 | 0.83138932 |
| 59 | PINK1 | 0.82333199 |
| 60 | PAK6 | 0.80838013 |
| 61 | CSNK1G3 | 0.80237292 |
| 62 | FGR | 0.79677948 |
| 63 | ADRBK1 | 0.79650609 |
| 64 | PAK1 | 0.79572042 |
| 65 | WNK3 | 0.78019385 |
| 66 | KDR | 0.77873640 |
| 67 | MAP3K2 | 0.77684164 |
| 68 | CAMK2D | 0.76570816 |
| 69 | MAPK13 | 0.75950354 |
| 70 | PKN1 | 0.75596970 |
| 71 | UHMK1 | 0.74835053 |
| 72 | CAMK2A | 0.74415986 |
| 73 | MAP3K14 | 0.74326146 |
| 74 | EIF2AK3 | 0.73811656 |
| 75 | TAOK1 | 0.73366094 |
| 76 | PTK2B | 0.72942404 |
| 77 | MAP3K4 | 0.72223790 |
| 78 | CAMKK2 | 0.71930909 |
| 79 | DAPK2 | 0.70770326 |
| 80 | CDK8 | 0.69801592 |
| 81 | TSSK6 | 0.69634423 |
| 82 | GRK6 | 0.69602058 |
| 83 | IRAK3 | 0.68137191 |
| 84 | ZAK | 0.66861313 |
| 85 | LRRK2 | 0.66238384 |
| 86 | CAMK2G | 0.65126370 |
| 87 | DDR2 | 0.64611508 |
| 88 | TBK1 | 0.64506781 |
| 89 | MINK1 | 0.64374519 |
| 90 | PRKG2 | 0.64036434 |
| 91 | PRKCE | 0.62166523 |
| 92 | DYRK3 | 0.61972828 |
| 93 | MAP3K13 | 0.61783840 |
| 94 | PAK4 | 0.61742425 |
| 95 | GRK1 | 0.60996786 |
| 96 | MAP3K9 | 0.58735979 |
| 97 | MAP2K6 | 0.57800101 |
| 98 | FES | 0.56829005 |
| 99 | NTRK1 | 0.56745162 |
| 100 | PHKG1 | 0.56724027 |
| 101 | PHKG2 | 0.56724027 |
| 102 | MOS | 0.56632925 |
| 103 | MAPKAPK3 | 0.55993668 |
| 104 | IKBKB | 0.55417581 |
| 105 | IRAK1 | 0.53755103 |
| 106 | CDK15 | 0.52784410 |
| 107 | MARK3 | 0.52608354 |
| 108 | LYN | 0.52501182 |
| 109 | CSNK2A1 | 0.52031782 |
| 110 | SRPK1 | 0.51925467 |
| 111 | TEC | 0.50963653 |
| 112 | INSRR | 0.47681165 |
| 113 | MAP2K2 | 0.46982530 |
| 114 | EPHA4 | 0.45716691 |
| 115 | MAP3K3 | 0.45338499 |
| 116 | CLK1 | 0.44793925 |
| 117 | AURKA | 0.44593541 |
| 118 | KIT | 0.43998561 |
| 119 | ILK | 0.43816675 |
| 120 | PRKCD | 0.42438314 |
| 121 | PRKCG | 0.42434046 |
| 122 | CDK14 | 0.42408840 |
| 123 | RPS6KA5 | 0.42155124 |
| 124 | CSNK2A2 | 0.42031634 |
| 125 | MAP2K4 | 0.42024980 |
| 126 | CSNK1G2 | 0.41501630 |
| 127 | EPHB2 | 0.40547519 |
| 128 | MAP3K5 | 0.40390506 |
| 129 | TYK2 | 0.40367709 |
| 130 | IRAK2 | 0.39996118 |
| 131 | PRKACA | 0.39848464 |
| 132 | LCK | 0.39756562 |
| 133 | IKBKE | 0.38250881 |
| 134 | YES1 | 0.38174656 |
| 135 | PRKCI | 0.38012186 |
| 136 | MARK1 | 0.37266052 |
| 137 | MAP3K11 | 0.37165096 |
| 138 | CDK5 | 0.36984869 |
| 139 | TNK2 | 0.36718289 |
| 140 | CDK11A | 0.36400508 |
| 141 | NUAK1 | 0.36231006 |
| 142 | RAF1 | 0.36222067 |
| 143 | MST1R | 0.36110749 |
| 144 | CDK18 | 0.35156910 |
| 145 | PIK3CG | 0.34204545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.07100372 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.01767125 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.92701178 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.91553176 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.48709395 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 3.47298325 |
| 7 | Protein export_Homo sapiens_hsa03060 | 3.29024701 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.11592450 |
| 9 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.88085439 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.97015837 |
| 11 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.91751465 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.91457776 |
| 13 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79620262 |
| 14 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.75268687 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.70810044 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40551081 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34500708 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34135627 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31540647 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31310913 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30726069 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24051214 |
| 23 | * Phagosome_Homo sapiens_hsa04145 | 1.18641759 |
| 24 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17990914 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15673627 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15064806 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07083281 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.06210463 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03634031 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00177503 |
| 31 | Asthma_Homo sapiens_hsa05310 | 0.97511633 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95061358 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95037091 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 0.94494355 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94452961 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 0.92499790 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92204915 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91141757 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 0.89720454 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89303832 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87507088 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85662468 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84379468 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 0.81834173 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80579481 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.80557683 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80426632 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79085114 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76827143 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75389734 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.75269889 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74225025 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73456723 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73236687 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.71123649 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68199485 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67742670 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.67275747 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.65511991 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.65229572 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64438032 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64327369 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61613770 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61452552 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61334492 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58685100 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57650994 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57334903 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56582356 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.56226575 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.55686806 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55337259 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53959236 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53723503 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52142724 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51507875 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50747603 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48325834 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47669525 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.46897267 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46682979 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46411415 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46029337 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45761776 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45473279 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.45176990 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43981393 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43155553 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42401237 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42101416 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.41527788 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41175117 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40096391 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39522805 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.39402583 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39355051 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39219146 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.37413528 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.36667562 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36547120 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35959091 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35726408 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35500930 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35449044 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35333472 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.34796585 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.34775682 |
| 108 | Salivary secretion_Homo sapiens_hsa04970 | 0.34497637 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33721005 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33525645 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33119221 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32981594 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32345917 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32122931 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31465148 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31191328 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30892728 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30064684 |
| 119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.29967029 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.29776029 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29245364 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.29156434 |
| 123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29122193 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.28730922 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28664451 |
| 126 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28557606 |
| 127 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27419706 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27366475 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27010260 |
| 130 | RNA degradation_Homo sapiens_hsa03018 | 0.25760136 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25420462 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.23969356 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23510238 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.22310925 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.22085459 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22027921 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21263082 |

